PTC Therapeutics, Inc. ( PTCT ) was a big mover last session, as its shares rose almost 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $29.77 to $33.92 in the past one-month time frame.
In the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher lasts.
PTC Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.
Other well-performing stocks in the med-drugs industry include Endo International plc ( ENDP ), Hyperion Therapeutics, Inc. ( HPTX ) and Lannett Company, Inc. ( LCI ). While Hyperion Therapeutics and Lannett Company sport a Zacks Rank #1 (Strong Buy), Endo International carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report